Clinical Trial Update: Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating exenatide long-acting release in adults with Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Exenatide long-acting release (exenatide long-acting release)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED